We are live on ! Find out more
BA

BlackRock Advisors Portfolio holdings

AUM $98.8B
1-Year Est. Return 15.8%
This Fund
S&P 500
This Quarter Est. Return
+4.87%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
10 Year Est. Return
AUM
$106B
AUM Growth
+$3.62B
Cap. Flow
-$1.47B
Cap. Flow %
-1.39%
Top 10 Hldgs %
14.33%
Holding
3,812
New
177
Increased
783
Reduced
2,146
Closed
145

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$281M
2
AMZN icon
Amazon
AMZN
+$228M
3
TWX
Time Warner Inc
TWX
+$219M
4
LLY icon
Eli Lilly
LLY
+$212M
5
RTX icon
RTX Corp
RTX
+$208M

Sector Composition

Rank Sector Weight
1 Financials 16.44%
2 Healthcare 15.11%
3 Industrials 11.28%
4 Energy 10.95%
5 Technology 7.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WUBA
876
DELISTED
58.com Inc
WUBA
$6.75M 0.01%
124,910
+92,010
+280% +$3.9M
DGII icon
877
Digi International
DGII
$2.52B
$6.72M 0.01%
713,011
-25,418
-3% -$232K
LMNS
878
DELISTED
LUMENIS LTD CL B ORD SHS (ISR)
LMNS
$6.67M 0.01%
684,800
+38,800
+6% +$360K
CLDX icon
879
Celldex Therapeutics
CLDX
$2.77B
$6.67M 0.01%
27,234
+19,980
+275% +$4.51M
WFC icon
880
PUT
Wells Fargo
WFC
$261B
$6.57M 0.01%
+125,000
New +$6.28M
ATI icon
881
ATI
ATI
$27B
$6.55M 0.01%
145,214
+498
+0.3% +$20.4K
PLX icon
882
Protalix BioTherapeutics
PLX
$191M
$6.55M 0.01%
179,436
+161
+0.1% +$6.49K
INFI
883
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
$6.5M 0.01%
510,519
-5,218
-1% -$54.4K
HNSN
884
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
$6.49M 0.01%
495,536
+69,650
+16% +$1.21M
CVEO icon
885
Civeo
CVEO
$379M
$6.49M 0.01%
+21,596
New +$6.46M
BANR icon
886
Banner Corp
BANR
$2.39B
$6.39M 0.01%
161,310
-46,975
-23% -$1.86M
CBRE icon
887
CBRE Group
CBRE
$40.8B
$6.32M 0.01%
197,280
-354,200
-64% -$10.2M
KEX icon
888
Kirby Corp
KEX
$7.95B
$6.31M 0.01%
53,901
+12,876
+31% +$1.38M
DRII
889
DELISTED
DIAMOND RESORTS INTL, INC
DRII
$6.3M 0.01%
270,916
-228,918
-46% -$4.49M
CP icon
890
Canadian Pacific Kansas City
CP
$82B
$6.3M 0.01%
173,830
+26,930
+18% +$883K
ARRY
891
DELISTED
Array Biopharma Inc
ARRY
$6.3M 0.01%
1,381,344
-328,920
-19% -$1.36M
GHDX
892
DELISTED
Genomic Health, Inc.
GHDX
$6.27M 0.01%
228,713
+216,065
+1,708% +$5.75M
RDY icon
893
Dr. Reddy's Laboratories
RDY
$9.82B
$6.24M 0.01%
723,215
-762,390
-51% -$6.41M
KMPR icon
894
Kemper
KMPR
$1.7B
$6.21M 0.01%
168,327
-48,605
-22% -$1.8M
YELP icon
895
Yelp
YELP
$1.38B
$6.18M 0.01%
80,546
-1,588,300
-95% -$103M
PRMW
896
DELISTED
Primo Water Corporation
PRMW
$6.17M 0.01%
872,860
-28,400
-3% -$213K
PLXS icon
897
Plexus
PLXS
$6.81B
$6.09M 0.01%
140,791
-39,777
-22% -$1.66M
HOT
898
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
$6.09M 0.01%
75,375
-155
-0.2% -$12.2K
AIN icon
899
Albany International
AIN
$2.14B
$6.09M 0.01%
160,372
+49,124
+44% +$1.79M
WBMD
900
DELISTED
WebMD Health Corp.
WBMD
$6.03M 0.01%
124,910
+7,348
+6% +$321K

Similar funds

BlackRock Advisors's Q2 2014 Portfolio in Review

As of Q2 2014, BlackRock Advisors held 3,812 positions worth $106B, up 3.5% from $102B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

BlackRock Advisors's Q2 2014 filing shows 177 new, 783 increased, 2,146 reduced and 145 closed positions. Its largest new stake was iShares US Financials ETF: 3,120,594 shares worth $130M. The largest sale was Pfizer, an estimated $281M.

By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 18% a quarter earlier, followed by Healthcare and Industrials.

  • BlackRock Advisors's largest Q2 2014 buy was iShares US Financials ETF: 3,120,594 shares worth $130M.
  • BlackRock Advisors added most to Apple in Q2 2014, an estimated $743M increase.
  • BlackRock Advisors's biggest Q2 2014 reduction was Pfizer, cutting an estimated $281M.
  • BlackRock Advisors fully exited PPL CORP CORP UITS CONSISTING OF PUR CONTRACT JR SUB NTS in Q2 2014, selling an estimated $40.9M.
  • BlackRock Advisors's ten largest holdings make up 14% of its $106B portfolio in Q2 2014.
  • BlackRock Advisors opened 177 new positions and closed 145 in Q2 2014.
  • BlackRock Advisors's portfolio value rose 3.5% quarter-over-quarter to $106B.

Based on BlackRock Advisors's 13F filing for Q2 2014, filed 6 Aug 2014.